Prognostic nomogram for patients with unresectable pancreatic cancer treated with gemcitabine plus nab-paclitaxel or FOLFIRINOX: A post-hoc analysis of a multicenter retrospective study in Japan (NAPOLEON study).

Autor: Shibuki, Taro1,2 (AUTHOR), Mizuta, Toshihiko1,3 (AUTHOR), Shimokawa, Mototsugu4,5 (AUTHOR), Koga, Futa6 (AUTHOR), Ueda, Yujiro7 (AUTHOR), Nakazawa, Junichi8 (AUTHOR), Komori, Azusa9 (AUTHOR), Otsu, Satoshi9 (AUTHOR), Arima, Shiho10 (AUTHOR), Fukahori, Masaru11 (AUTHOR), Makiyama, Akitaka12,13 (AUTHOR), Taguchi, Hiroki14,15 (AUTHOR), Honda, Takuya16 (AUTHOR), Mitsugi, Kenji17,18 (AUTHOR), Nio, Kenta17,18 (AUTHOR), Ide, Yasushi19 (AUTHOR), Ureshino, Norio20,21 (AUTHOR), Shirakawa, Tsuyoshi22,23 (AUTHOR) twriver1979@gmail.com, Otsuka, Taiga20,24 (AUTHOR)
Zdroj: BMC Cancer. 1/3/2022, Vol. 22 Issue 1, p1-11. 11p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje